Luis Carvajal-Carmona, PhD

Gastric cancer is the second worldwide cause of cancer-related death and a malignancy associated with considerable

incidence and survival disparities. Our research laboratory is currently funded by the NCI to carry out studies on gastric

cancer genetics and genomics and to develop precision medicine approaches to understand tumor evolution and to develop new molecularly guided therapies. The talk will focus on progress in these aspects and will provide an overview of the key research gaps that are needed to advance precision prevention and treatment of gastric cancer.